Citation Impact
Citing Papers
A Gene Expression Signature that Can Predict the Recurrence of Tamoxifen-Treated Primary Breast Cancer
2008
CYP2A6: genetics, structure, regulation, and function
2012
Breast cancer
2019 Standout
Hypoxia-Inducible Factors and the Response to Hypoxic Stress
2010 Standout
Overcoming Endocrine Therapy Resistance by Signal Transduction Inhibition
2004
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
2014 Standout
Establishing, maintaining and modifying DNA methylation patterns in plants and animals
2010 Standout
Mechanisms of SARS-CoV-2 entry into cells
2021 Standout
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Estrogen receptors and human disease
2006 Standout
Epigenetic gene silencing in the Wnt pathway in breast cancer
2008
ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood–brain barrier
2008
Acetylation of nuclear receptors in cellular growth and apoptosis
2004
Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells
2008
FOXP3+ regulatory T cells: control of FOXP3 expression by pharmacological agents
2011 StandoutNobel
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
Wnt signaling in cancer
2016 Standout
Structure and function of the blood–brain barrier
2009 Standout
Cancer genetics of epigenetic genes
2007
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
Chromatin‐modifying proteins in cancer
2007
Structure and function of long noncoding RNAs in epigenetic regulation
2013 Standout
Inter-laboratory quality control for hormone-dependent gene expression in human breast tumors using real-time reverse transcription-polymerase chain reaction
2004
Central Role of RET in Thyroid Cancer
2013
ERβ Impedes Prostate Cancer EMT by Destabilizing HIF-1α and Inhibiting VEGF-Mediated Snail Nuclear Localization: Implications for Gleason Grading
2010
Human CYP2A6 Is Induced by Estrogen via Estrogen Receptor
2007
Glutaminase 1 expression in colorectal cancer cells is induced by hypoxia and required for tumor growth, invasion, and metastatic colonization
2019 StandoutNobel
Epigenetics in Cancer
2008 Standout
Significance, detection and markers of disseminated breast cancer cells
2006
Anticancer activities of histone deacetylase inhibitors
2006 Standout
Epigenetics in cancer
2009 Standout
DNA hypomethylation and human diseases
2006
Estrogen Receptor Beta (ESR2) Polymorphisms in Familial and Sporadic Breast Cancer
2005
Regulatory T cells, tumour immunity and immunotherapy
2006 Standout
Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis
2006
Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma
2011
Xenobiotic-Metabolizing Enzymes and Transporters in the Normal Human Brain: Regional and Cellular Mapping as a Basis for Putative Roles in Cerebral Function
2009
DNA methylation landscapes: provocative insights from epigenomics
2008 Standout
Pregnancy and the risk of breast cancer
2007
Causes and consequences of microRNA dysregulation in cancer
2009 Standout
Novel estrogen receptor coregulators and signaling molecules in human diseases
2004
Type II transmembrane serine proteases in development and disease
2007
Autophagy modulation as a potential therapeutic target for diverse diseases
2012 Standout
Decitabine—Bedside to bench
2006
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy
2003
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues
2007
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
2005 Standout
Epigenetic modifications and human disease
2010 Standout
Effects of Atrazine on CYP19 Gene Expression and Aromatase Activity in Testes and on Plasma Sex Steroid Concentrations of Male African Clawed Frogs (Xenopus laevis)
2005
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
2006 Standout
A decade of exploring the cancer epigenome — biological and translational implications
2011 Standout
Genome‐wide array‐based comparative genomic hybridization analysis of pancreatic adenocarcinoma: Identification of genetic indicators that predict patient outcome
2007
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family
2009
An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System
2005 Standout
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
2012 StandoutNobel
Pancreatic cancer
2011 Standout
Mechanisms of implantation: strategies for successful pregnancy
2012 Standout
Epigenetics and cancer
2004
Plasmacytoid Dendritic Cells Induce CD8+ Regulatory T Cells In Human Ovarian Carcinoma
2005
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Estrogen Receptors as Therapeutic Targets in Breast Cancer
2008
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Natural Innate and Adaptive Immunity to Cancer
2011 Standout
Estrogen Receptor-β: Recent Lessons from in Vivo Studies
2006
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Cell Cycle Progression Stimulated by Tamoxifen-Bound Estrogen Receptor-α and Promoter-Specific Effects in Breast Cancer Cells Deficient in N-CoR and SMRT
2005
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
2016 Standout
The Effects of Cadmium Toxicity
2020 Standout
Epigenetics and epigenetic alterations in pancreatic cancer.
2009
Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators
2004
Cancer treatment and survivorship statistics, 2016
2016 Standout
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Cancer treatment and survivorship statistics, 2019
2019 Standout
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
2008 Standout
Evidence for functional estrogen receptors α and β in human adipose cells: regional specificities and regulation by estrogens
2004
A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling
2005 StandoutScience
Non‐competitive steroid inhibition of oestrogen receptor functions
2002
Interleukin-2 Administration Alters the CD4+FOXP3+ T-Cell Pool and Tumor Trafficking in Patients with Ovarian Carcinoma
2007
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B
2007
Bone Marrow Is a Reservoir for CD4+CD25+ Regulatory T Cells that Traffic through CXCL12/CXCR4 Signals
2004
Tumor Suppressor Gene Inactivation during Cadmium-Induced Malignant Transformation of Human Prostate Cells Correlates with Overexpression of de Novo DNA Methyltransferase
2007
Regulation of DNA Methyltransferase 1 by the pRb/E2F1 Pathway
2005
Robust Distal Tip Cell Pathfinding in the Face of Temperature Stress Is Ensured by Two Conserved microRNAS inCaenorhabditis elegans
2015 StandoutNobel
Cancer treatment and survivorship statistics, 2014
2014 Standout
Works of Igor Girault being referenced
Quantification of estrogen receptor α and β expression in sporadic breast cancer
2001
Prognostic value of maspin mRNA expression in ERα-positive postmenopausal breast carcinomas
2003
SIMULTANEOUS MEASUREMENT OF 23 ISOFORMS FROM THE HUMAN CYTOCHROME P450 FAMILIES 1 TO 3 BY QUANTITATIVE REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION
2005
Altered expression pattern of alternatively spliced estrogen receptor β transcripts in breast carcinoma
2004
Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma
2004
Evaluation of mRNA expression of estrogen receptor β and its isoforms in human normal and neoplastic endometrium
2004
Real-time reverse transcription PCR assay of CYP19 expression: application to a well-defined series of post-menopausal breast carcinomas
2002
Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach
2006
Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.
2003
Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.
2003
Role of estrogen receptor α transcriptional coregulators in tamoxifen resistance in breast cancer
2006